AU1210401A - Prevention of plaque rupture by acat inhibitors - Google Patents

Prevention of plaque rupture by acat inhibitors Download PDF

Info

Publication number
AU1210401A
AU1210401A AU12104/01A AU1210401A AU1210401A AU 1210401 A AU1210401 A AU 1210401A AU 12104/01 A AU12104/01 A AU 12104/01A AU 1210401 A AU1210401 A AU 1210401A AU 1210401 A AU1210401 A AU 1210401A
Authority
AU
Australia
Prior art keywords
phenyl
methylethyl
bis
sulfamic acid
phenyl ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12104/01A
Other languages
English (en)
Inventor
Thomas Michael Andrew Bocan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU1210401A publication Critical patent/AU1210401A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
AU12104/01A 1999-11-05 2000-10-17 Prevention of plaque rupture by acat inhibitors Abandoned AU1210401A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16381499P 1999-11-05 1999-11-05
US60163814 1999-11-05
PCT/US2000/028705 WO2001034127A1 (fr) 1999-11-05 2000-10-17 Prevention de la rupture de plaques par inhibiteurs de l'acat

Publications (1)

Publication Number Publication Date
AU1210401A true AU1210401A (en) 2001-06-06

Family

ID=22591694

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12104/01A Abandoned AU1210401A (en) 1999-11-05 2000-10-17 Prevention of plaque rupture by acat inhibitors

Country Status (19)

Country Link
EP (1) EP1229907A1 (fr)
JP (1) JP2003513909A (fr)
KR (1) KR20020050257A (fr)
CN (1) CN1414848A (fr)
AR (1) AR026354A1 (fr)
AU (1) AU1210401A (fr)
CA (1) CA2382676A1 (fr)
CO (1) CO5270017A1 (fr)
GT (1) GT200000193A (fr)
HU (1) HUP0203160A3 (fr)
IL (1) IL149145A0 (fr)
PA (1) PA8506101A1 (fr)
PE (1) PE20011027A1 (fr)
PL (1) PL355148A1 (fr)
SV (1) SV2001000207A (fr)
TR (1) TR200201204T2 (fr)
UY (1) UY26427A1 (fr)
WO (1) WO2001034127A1 (fr)
ZA (1) ZA200201755B (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2358734C2 (ru) 2003-08-29 2009-06-20 Кова Ко., Лтд. Способ стабилизации бляшки с высоким содержанием липидов и способ профилактики ее разрушения
JP2007532617A (ja) * 2004-04-15 2007-11-15 アテラ バイオテクノロジーズ エービー アテローム血栓症およびプラーク破壊を予防するためのアネキシンｖ
NZ608903A (en) 2010-11-03 2014-06-27 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
AU2012329045A1 (en) 2011-10-26 2014-04-17 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US9708288B2 (en) 2012-04-27 2017-07-18 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US20130291227A1 (en) 2012-04-27 2013-10-31 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
CA2925873A1 (fr) 2013-10-17 2015-04-23 Dow Agrosciences Llc Procedes de preparation de de composes pesticides
MX2016004942A (es) 2013-10-17 2016-06-28 Dow Agrosciences Llc Procesos para la preparacion de compuestos plaguicidas.
US9029554B1 (en) 2013-10-17 2015-05-12 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
BR112016007518A2 (pt) 2013-10-17 2017-08-01 Dow Agrosciences Llc processos para a preparação de compostos pesticidas
JP6487426B2 (ja) 2013-10-17 2019-03-20 ダウ アグロサイエンシィズ エルエルシー 有害生物防除化合物の調製法
CN105636442B (zh) 2013-10-17 2018-04-27 美国陶氏益农公司 制备杀虫化合物的方法
EP3057428A4 (fr) 2013-10-17 2017-05-17 Dow AgroSciences LLC Procédés de préparation de composés pesticides
CN105792652A (zh) 2013-10-22 2016-07-20 美国陶氏益农公司 协同杀虫组合物和相关方法
US9295260B2 (en) 2013-10-22 2016-03-29 Dow Agrosciences Llc Pesticidal compositions and related methods
TW201517797A (zh) 2013-10-22 2015-05-16 Dow Agrosciences Llc 協同性殺蟲組成物及相關方法（十一）
US9474276B2 (en) 2013-10-22 2016-10-25 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
US9801383B2 (en) 2013-10-22 2017-10-31 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
WO2015061140A1 (fr) 2013-10-22 2015-04-30 Dow Agrosciences Llc Compositions pesticides synergiques et méthodes associées
JP2016535739A (ja) 2013-10-22 2016-11-17 ダウ アグロサイエンシィズ エルエルシー 農薬組成物および関連する方法
MX2016005317A (es) 2013-10-22 2016-08-12 Dow Agrosciences Llc Composiciones pesticidas y metodos relacionados.
RU2016119368A (ru) 2013-10-22 2017-11-28 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Синергетические пестицидные композиции и связанные с ними способы
NZ719754A (en) 2013-10-22 2017-06-30 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
AR098096A1 (es) 2013-10-22 2016-05-04 Dow Agrosciences Llc Composiciones plaguicidas sinérgicas y métodos relacionados
JP2016535024A (ja) 2013-10-22 2016-11-10 ダウ アグロサイエンシィズ エルエルシー 相乗的有害生物防除組成物および関連する方法
NZ719688A (en) 2013-10-22 2017-06-30 Dow Agrosciences Llc Pesticidal compositions and related methods
KR20160074582A (ko) 2013-10-22 2016-06-28 다우 아그로사이언시즈 엘엘씨 상승작용적 살충 조성물 및 관련 방법
WO2015061163A1 (fr) 2013-10-22 2015-04-30 Dow Agrosciences Llc Compositions pesticides et procédés associés
JP2016538266A (ja) 2013-10-22 2016-12-08 ダウ アグロサイエンシィズ エルエルシー 相乗的有害生物防除組成物および関連する方法
MX2016005323A (es) 2013-10-22 2016-08-12 Dow Agrosciences Llc Composiciones pesticidas y metodos relacionados.
KR20170038785A (ko) 2014-07-31 2017-04-07 다우 아그로사이언시즈 엘엘씨 3-(3-클로로-1h-피라졸-1-일)피리딘의 제조 방법
BR112017000565A2 (pt) 2014-07-31 2017-11-07 Dow Agrosciences Llc processo para a preparação de 3-(3-cloro-1h-pirazol-1-il)piridina
JP2017523168A (ja) 2014-07-31 2017-08-17 ダウ アグロサイエンシィズ エルエルシー ３−（３−クロロ−１ｈ−ピラゾール−１−イル）ピリジンの製造方法
WO2016028328A1 (fr) 2014-08-19 2016-02-25 Dow Agrosciences Llc Procédé de préparation de 3-(3-chloro-1h-pyrazol-1-yl)pyridine
US9085552B1 (en) 2014-09-12 2015-07-21 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
EP3209671B8 (fr) * 2014-10-21 2019-07-31 Council of Scientific and Industrial Research Esters de phosphonate d'alkylidène en tant qu'inducteurs de p-glycoprotéine
PE20190656A1 (es) * 2016-07-29 2019-05-08 Lupin Ltd Compuestos de tiazolo-piridina sustituida como inhibidores de malt1
WO2018093966A1 (fr) 2016-11-16 2018-05-24 Purdue Research Foundation Compositions et procédés de régulation du poids corporel et des syndromes métaboliques
US10233155B2 (en) 2016-12-29 2019-03-19 Dow Agrosciences Llc Processes for the preparation of pesticide compounds
CN110139853B (zh) 2016-12-29 2023-06-16 美国陶氏益农公司 用于制备杀有害生物化合物的方法
AU2018354777A1 (en) 2017-10-27 2020-04-16 Bayer Aktiengesellschaft Novel Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors
WO2020113094A1 (fr) 2018-11-30 2020-06-04 Nuvation Bio Inc. Composés pyrrole et pyrazole et leurs procédés d'utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU654688B2 (en) * 1990-10-30 1994-11-17 Warner-Lambert Company Oxysulfonyl carbamates
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
IT1270976B (it) * 1993-08-06 1997-05-26 Pierrel Spa Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica, loro uso e composizioni farmaceutiche che li contengono
JPH11510184A (ja) * 1995-08-04 1999-09-07 ワーナー−ランバート・コンパニー リポ蛋白レベルを低下させるための医薬の製造用スルファミン酸誘導体、アシルスルホンアミドまたはスルホニルカルバメートの使用
CN1217656C (zh) * 1995-11-02 2005-09-07 沃尼尔·朗伯公司 用于调节脂浓度的方法和药物组合物
IL140982A0 (en) * 1998-07-21 2002-02-10 Warner Lambert Co Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions

Also Published As

Publication number Publication date
KR20020050257A (ko) 2002-06-26
PA8506101A1 (es) 2002-10-28
ZA200201755B (en) 2003-08-27
PL355148A1 (en) 2004-04-05
GT200000193A (es) 2002-04-27
WO2001034127A1 (fr) 2001-05-17
AR026354A1 (es) 2003-02-05
CO5270017A1 (es) 2003-04-30
HUP0203160A2 (hu) 2003-01-28
IL149145A0 (en) 2002-11-10
HUP0203160A3 (en) 2006-02-28
CA2382676A1 (fr) 2001-05-17
SV2001000207A (es) 2001-10-16
PE20011027A1 (es) 2001-10-16
CN1414848A (zh) 2003-04-30
UY26427A1 (es) 2000-12-29
TR200201204T2 (tr) 2002-08-21
JP2003513909A (ja) 2003-04-15
EP1229907A1 (fr) 2002-08-14

Similar Documents

Publication Publication Date Title
AU1210401A (en) Prevention of plaque rupture by acat inhibitors
RU2668972C2 (ru) Диарил-спирогидантоиновые соединения, полезные при лечении гиперпролиферативного нарушения
US5075323A (en) Compounds including omeprazole in the treatment of glaucoma
KR20010032304A (ko) 알도스 환원효소 억제제 및 글리코겐 포스포릴라제억제제의 혼합물
EP2606890A1 (fr) Combinaisons d'inhibiteurs de BCR-ABL/C-KIT/PDGF-R TK pour traiter le cancer
JP2004538266A (ja) ピラゾール由来のキナーゼインヒビター
TW201517900A (zh) 使用甲醯基肽受體２激動劑治療眼部發炎性疾病
EP2616066B1 (fr) Promédicaments de type ester de [3-(1-(1h-imidazol-4-yl)éthyl)-2-méthylphényl]méthanol pour le traitement de maladies rétiniennes
CN105228982A (zh) 用于治疗过度增殖性病症的3-乙酰基氨基-1-(苯基-杂芳基-氨基羰基或苯基-杂芳基-羰基氨基)苯衍生物
US20020168424A1 (en) Nitric oxide (NO) donor+cGMP-PDE5 inhibitor as a topical drug for glaucoma
JP2003518101A (ja) カリウムチャネル阻害剤
AU4508601A (en) Inhibitors of collagen-induced platelet aggregation
RU2763525C2 (ru) Комбинированная терапия для лечения легочной гипертензии
AU2002352227B2 (en) Benzazole derivatives for the treatment of scleroderma
EP3761989A1 (fr) Imidazodiazépinediones et leurs procédés d'utilisation
RU2173148C2 (ru) Средство для профилактики и лечения диабетических осложнений
EP3730138B1 (fr) Combinaison de sepetaprost et de ripasudil pour l'utilisation dans la prophylaxie ou le traitement du glaucome ou de l'hypertension oculaire
JP2000500490A (ja) 糖尿病治療用の４−ヒドロキシクマリン−３−カルボキシアミド
US8198284B2 (en) Treatment of neurodegenerative disorders with thiourea compounds
US8383662B2 (en) Bicyclic heteroaryl compounds
CA3073128A1 (fr) Amelioration de l'efficacite de traitement du cancer par l'intermediaire de la voie sphingosine-1-phosphate
KR20240100765A (ko) 퀴나졸린계 화합물을 유효성분으로 포함하는 아토피 예방, 개선 또는 치료용 조성물
WO2004030674A1 (fr) Nouvelles utilisations de la prostaglandine d2, agoniste de la prostaglandine d2 et antagoniste de la prostaglandine d2
JP2024515148A (ja) １，２，４，５－テトラオキサン化合物の標的化送達及びその使用
TW202222314A (zh) 神經鞘胺醇－１－磷酸受體促效劑的用途

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period